COVID-19 Frontline Therapies: Navigating Through This Health Crisis and Optimizing Patient Care

Download Toolkit

PROGRAM SPEAKER 

Brian Nyquist, MPH President & CEO National Infusion Center Association Executive Director of the Infusion Access Foundation Austin, TX

PROGRAM OVERVIEW

This COVID-19 FRONTLINE podcast provides an update to new monoclonal antibody infusion therapies approved for emergency use for the treatment of COVID-19. Each podcast focuses on different issues facing clinicians, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and other important topics.

TARGET AUDIENCE

This CME initiative is designed for HCPs who are involved in the care and treatment of patients with COVID-19, including physicians, NPs, PAs, nurses, and pharmacists across emergency medicine, primary care, family medicine, infusion centers, and the Department of Veteran Affairs.

LEARNING OBJECTIVE

On completing this program, attendees should be able to:

• Assess the rationale for the use of new virus-neutralizing monoclonal antibodies to mitigate the risk of viral resistance to therapy
• Develop in-clinic infusion capability to administer new virus-neutralizing monoclonal antibodies to patients with COVID-19 at the point-of-care
• Use guidance and resources developed to promote safe and responsible use of infusion therapies for treating patients with COVID-19

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Mr. Nyquist has nothing to disclose. CME Content Review The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose. CNE Content Review The content of this activity was peer reviewed by a nurse reviewer. The reviewer of this activity has nothing to disclose. Staff Planners and Managers The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity: Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose. Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose. Angela Davis, PhD, Medical Director for Med Learning Group, has nothing to disclose. Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose. Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose. Morgan Kravarik, Program Coordinator for Med Learning Group, has nothing to disclose. Brianna Hanson, Accreditation and Outcomes Coordinator, has nothing to disclose. 

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating in this online activity.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making experience before applying any information, whether provided here or by others, for any professional use. For CME questions, please contact Med Learning Group at [email protected] Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITY ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Provided by Med Learning Group

Co-provided by Ultimate Medical Academy/Complete Conference Management (CCM).

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only.  Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.